PHAR 340 TP Questions Exam 2

Question

Approx what % of hospitals utilize "UD" drug distribution?

Answer 1

Pharmacokinetic Consultations

Answer 2

Drug use evaluation (DUE)

Answer 3

Participation on medical rounds

Answer 4

Adverse Drug Reaction management

Answer 5

In-service Education

Answer 6

homemaker services

Answer 7

wound care

Answer 8

parenteral nutrition

Answer 9

minor home surgery

Answer 10

hospice care

Answer 11

is nearly all federally-based

Answer 12

has shifted amongst payors for many years

Answer 13

follows the 1910 Flexner recommendation

Answer 14

is nearly all state-based

Answer 15

none of the above

Answer 16

increase risk of drug interaction issues

Answer 17

increased risk of medication adherence problems

Answer 18

increased difficulty in communication

Answer 19

the same need for compassionate care

Answer 20

all of the above

Answer 21

higher than skilled nursing care

Answer 22

approximately $3300/month (2010 data)

Answer 23

approximately $200/bed/day (2010 data)

Answer 24

covered by Medicare

Answer 25

none of the above

Answer 26

Persons with co -occurring disorders often have more instances of premature death and higher rates of disability that hose who don’t have co -occurring disorder.

Answer 27

Persons with co -occurring disorders do not have more instances of premature death and higher rates of disability that hose who don’t have co -occurring disorder.

Answer 28

From 2008 to 2014, there is a projected 6.6% annual decrease in spending for mental health and substance use services in the US.

Answer 29

From 2008 to 2014, there is a projected 6.6% annual increase in spending for mental health and substance use services in the US.

Answer 30

There will not be a % change in spending for mental health during this period in the US.

Answer 31

Cultural and linguistic minorities

Answer 32

Rural populations

Answer 33

Women and children in lower socio-economics

Answer 34

Cultural and linguistic minorities & Rural populations only

Answer 35

All of the above

Answer 36

Is supported by research that is published in the clinical literature

Answer 37

The type of practice that is the basis of curriculum now offered by healthcare professions’ schools and colleges

Answer 38

Clinical literature that is reviewed and summarized by professionals with expertise in the specific area

Answer 39

All of the above

Answer 40

None of the above

Answer 41

Provide medication management services

Answer 42

Initiate and discontinue med use

Answer 43

Dose and refill authorizations

Answer 44

Laboratory monitoring

Answer 45

All of the above

Answer 46

Education (e.g., Training in pharmacotherapeutics; Preceptors’ prescribing habits)

Answer 47

Control and regulatory mechanisms

Answer 48

Demands by consumers and society

Answer 49

Promotional activities by drug manufacturers

Answer 50

All of the above

Answer 51

Raw Material Supply -> Manufacturing -> Distribution -> Dispensing -> Patient

Answer 52

Raw Material Supply -> Patient -> Manufacturing -> Distribution -> Dispensing

Answer 53

Raw Material Supply Dispensing -> Patient -> Manufacturing -> Distribution

Answer 54

None of the above

Answer 55

Once a drug is approved for the market, the FDA has the ultimate power to determine how it is ultimately used.

Answer 56

Non -FDA -approved (“off -label”) indications are uses of a product that were not approved by the FDA, but have shown value after approval based on postmarketing research.

Answer 57

Non -FDA -approved indications cannot be promoted by the manufacturer.

Answer 58

None of the above

Answer 59

A. All printed information accompanying a drug, label, wrapping & package insert

Answer 60

B. FDA Division of Marketing, Advertising & Communication seeks balanced, not misleading, scientifically accurate information for health care practitioners

Answer 61

C. Label claim (indication) is particularly important to sponsor because of its connection to reimbursement

Answer 62

D. A and B only

Answer 63

All of the above

Answer 64

Prices of related goods

Answer 65

Money income of the producer

Answer 66

Number of consumers in the market

Answer 67

Attitudes, tastes, and preferences of the consumer

Answer 68

Consumer expectations with respect to future prices and incomes

Answer 69

Techniques of production, including technology

Answer 70

Number of buyers in the market

Answer 71

Resource costs (material and wages)

Answer 72

Prices for related goods

Answer 73

Sellers’ expectations

Answer 74

None of the above

Answer 75

Wound care

Answer 76

Parenteral nutrition

Answer 77

Minor home surgery

Answer 78

Hospice care

Answer 79

Hospice services cannot legally be provided in a patient's home in most states.

Answer 80

Hospice services can legally be provided in a patient's home in most states.

Answer 81

The size and weight of infusion devices have decreased dramatically

Answer 82

Manufacturers have introduced disposable infusion devices

Answer 83

Pharmacists can only administer them

Answer 84

All of the above

Answer 85

Initial patient database and assessment

Answer 86

Selection of products, devices, and ancillary supplies

Answer 87

Clinical monitoring

Answer 88

Initial patient database and assessment & Clinical monitoring only

Answer 89

All of the above

Próximo

PHAR 340 TP Questions Exam 2

Descrição

Resumo de Recurso

Questão 1

Questão 2

Questão 3

Questão 4

Questão 5

Questão 6

Questão 7

Questão 8

Questão 9

Questão 10

Questão 11

Questão 12

Questão 13

Questão 14

Questão 15

Questão 16

Questão 17

Questão 18

Questão 19

Questão 20

Questão 21

Questão 22

Questão 23

Questão 24

Questão 25

Questão 26

Questão 27

Questão 28

Questão 29

Semelhante

	Criado por Kevin Vu mais de 8 anos atrás